Note: Neurona Therapeutics's revenues are gauged from an analysis of company filings.
Neurona Therapeutics's Income Statement (based on Industry Averages)
Neurona Therapeutics P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
Neurona Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
February 13, 2024
35
100%
$120 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Neurona Therapeutics is developing and marketing.
Neurona Therapeutics doesn't have any recent trademark applications, indicating Neurona Therapeutics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
NEURONA stem cells for medical purposes; interneuron transplants for medical purposes; cellular therapy products, namely, therapeutic cells for use in treatment of neurological and neuropsychiatric disorders, neuropathic pain and neurodegenerative disease
05/06/2015
See all trademarks and details in the Full Report.
Market Share of Neurona Therapeutics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Neurona Therapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Neurona Therapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Neurona Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.